Thermo Fisher Scientific Company Profile (NYSE:TMO)

About Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific logoThermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables. The Analytical Instruments segment provides a range of instruments, consumables, software and services. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers controlled temperature technologies products, growth protection and separation products, and water and laboratory products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NYSE:TMO
  • CUSIP: 88355610
  • Web:
  • Market Cap: $75.20293 billion
  • Outstanding Shares: 390,119,000
Average Prices:
  • 50 Day Moving Avg: $181.07
  • 200 Day Moving Avg: $171.15
  • 52 Week Range: $139.07 - $194.30
  • Trailing P/E Ratio: 32.80
  • Foreward P/E Ratio: 17.76
  • P/E Growth: 1.72
Sales & Book Value:
  • Annual Revenue: $19.2 billion
  • Price / Sales: 3.83
  • Book Value: $57.40 per share
  • Price / Book: 3.28
  • Annual Dividend: $0.60
  • Dividend Yield: 0.3%
  • EBIDTA: $4.81 billion
  • Net Margins: 11.80%
  • Return on Equity: 15.97%
  • Return on Assets: 7.48%
  • Debt-to-Equity Ratio: 0.68%
  • Current Ratio: 1.47%
  • Quick Ratio: 0.99%
  • Average Volume: 1.44 million shs.
  • Beta: 1.05
  • Short Ratio: 1.66

Frequently Asked Questions for Thermo Fisher Scientific (NYSE:TMO)

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific declared a quarterly dividend on Wednesday, July 12th. Stockholders of record on Friday, September 15th will be given a dividend of $0.15 per share on Monday, October 16th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date of this dividend is Thursday, September 14th. View Thermo Fisher Scientific's Dividend History.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc (NYSE:TMO) announced its quarterly earnings data on Wednesday, July, 26th. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.03. The company had revenue of $5 billion for the quarter, compared to analyst estimates of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. Thermo Fisher Scientific's revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.03 earnings per share. View Thermo Fisher Scientific's Earnings History.

When will Thermo Fisher Scientific make its next earnings announcement?

Thermo Fisher Scientific is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for Thermo Fisher Scientific.

Where is Thermo Fisher Scientific's stock going? Where will Thermo Fisher Scientific's stock price be in 2017?

15 analysts have issued 12 month price objectives for Thermo Fisher Scientific's stock. Their predictions range from $162.00 to $220.00. On average, they anticipate Thermo Fisher Scientific's share price to reach $194.38 in the next year. View Analyst Ratings for Thermo Fisher Scientific.

Who are some of Thermo Fisher Scientific's key competitors?

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the folowing people:

  • Jim P. Manzi, Independent Chairman of the Board
  • Marc N. Casper, President, Chief Executive Officer, Director
  • Stephen Williamson, Chief Financial Officer, Senior Vice President
  • Mark P. Stevenson, Chief Operating Officer, Executive Vice President, President, Life Sciences Solutions
  • Seth H. Hoogasian, Senior Vice President, General Counsel, Secretary
  • Patrick M. Durbin, Senior Vice President, President - Specialty Diagnostics
  • Thomas W. Loewald, Senior Vice President, Chief Commercial Officer
  • Daniel P. Shine, Senior Vice President, President, Analytical Instruments
  • Peter E. Hornstra, Vice President, Chief Accounting Officer
  • Dion J. Weisler, Director

Who owns Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.82%), BlackRock Inc. (5.99%), Capital Research Global Investors (4.44%), State Street Corp (4.09%), Capital World Investors (3.01%) and Longview Partners Guernsey LTD (1.09%). Company insiders that own Thermo Fisher Scientific stock include Alan J Malus, C Martin Harris, Daniel P Shine, Gregory J Herrema, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Scott M Sperling, Seth H Hoogasian, Stephen Williamson, Thomas W Loewald and William G Parrett. View Institutional Ownership Trends for Thermo Fisher Scientific.

Who sold Thermo Fisher Scientific stock? Who is selling Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Standard Life Investments LTD, Winslow Capital Management LLC, TIAA CREF Investment Management LLC, Karp Capital Management Corp, Bank of New York Mellon Corp, Ameriprise Financial Inc. and Glenview Capital Management LLC. Company insiders that have sold Thermo Fisher Scientific stock in the last year include C Martin Harris, Daniel P Shine, Gregory J Herrema, Jim P Manzi, Marc N Casper, Peter E Hornstra, Peter M Wilver, Seth H Hoogasian, Stephen Williamson and Thomas W Loewald. View Insider Buying and Selling for Thermo Fisher Scientific.

Who bought Thermo Fisher Scientific stock? Who is buying Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock was bought by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Janus Henderson Group PLC, Veritas Asset Management LLP, Harbour Capital Advisors LLC, Capital World Investors, Vanguard Group Inc., Koch Industries Inc. and Investec Asset Management LTD. View Insider Buying and Selling for Thermo Fisher Scientific.

How do I buy Thermo Fisher Scientific stock?

Shares of Thermo Fisher Scientific can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of Thermo Fisher Scientific stock can currently be purchased for approximately $188.30.

MarketBeat Community Rating for Thermo Fisher Scientific (NYSE TMO)
Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  479 (Vote Outperform)
Underperform Votes:  217 (Vote Underperform)
Total Votes:  696
MarketBeat's community ratings are surveys of what our community members think about Thermo Fisher Scientific and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Thermo Fisher Scientific (NYSE:TMO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 13 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $194.38 (3.23% upside)

Analysts' Ratings History for Thermo Fisher Scientific (NYSE:TMO)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/10/2017Cowen and CompanyReiterated RatingOutperform$200.00 -> $220.00LowView Rating Details
9/6/2017Morgan StanleyReiterated RatingOverweight -> Overweight$220.00MediumView Rating Details
8/22/2017ArgusReiterated RatingBuyMediumView Rating Details
7/21/2017Bank of America CorporationReiterated RatingBuy$200.00 -> $210.00LowView Rating Details
7/20/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
7/17/2017Barclays PLCReiterated RatingOverweight$190.00 -> $200.00LowView Rating Details
7/13/2017Wells Fargo & CompanyReiterated RatingOutperform$195.00 -> $200.00LowView Rating Details
7/10/2017Citigroup Inc.Reiterated RatingBuy$182.00 -> $201.00LowView Rating Details
6/10/2017Deutsche Bank AGSet Price TargetBuy$200.00LowView Rating Details
5/18/2017Cantor FitzgeraldInitiated CoverageOverweight -> Overweight$194.00LowView Rating Details
5/17/2017Jefferies Group LLCReiterated RatingHold$175.00LowView Rating Details
4/28/2017BTIG ResearchBoost Price TargetBuy$180.00 -> $190.00LowView Rating Details
4/27/2017Leerink SwannSet Price TargetBuy$187.00LowView Rating Details
1/31/2017Evercore ISIBoost Price TargetBuy$160.00 -> $162.00N/AView Rating Details
12/12/2016Goldman Sachs Group, Inc. (The)Reiterated RatingConviction-Buy -> Conviction-Buy$170.00 -> $168.00N/AView Rating Details
9/22/2016J P Morgan Chase & CoInitiated CoverageOverweight$180.00N/AView Rating Details
7/28/2016MizuhoSet Price TargetBuy$170.00 -> $175.00N/AView Rating Details
3/2/2016Topeka Capital MarketsBoost Price TargetBuy$145.00 -> $155.00N/AView Rating Details
1/29/2016Stifel NicolausLower Price Target$158.00 -> $150.00N/AView Rating Details
1/29/2016KeyCorpLower Price TargetOverweight$152.00 -> $150.00N/AView Rating Details
1/6/2016Avondale PartnersInitiated CoverageOutperform$168.00N/AView Rating Details
(Data available from 9/23/2015 forward)


Earnings History for Thermo Fisher Scientific (NYSE:TMO)
Earnings by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Earnings History by Quarter for Thermo Fisher Scientific (NYSE TMO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017$2.24N/AView Earnings Details
7/26/2017Q2 2017$2.27$2.30$4.92 billion$5.00 billionViewN/AView Earnings Details
4/26/2017Q1 2017$2.02$2.08$4.68 billion$4.77 billionViewN/AView Earnings Details
1/31/2017Q416$2.38$2.41$4.98 billion$4.95 billionViewN/AView Earnings Details
10/27/2016Q316$1.97$2.03$4.39 billion$4.49 billionViewListenView Earnings Details
7/28/2016Q216$2.01$2.03$4.50 billion$4.54 billionViewListenView Earnings Details
4/28/2016Q116$1.74$1.80$4.11 billion$4.29 billionViewListenView Earnings Details
1/28/2016Q415$2.11$2.12$4.55 billion$4.65 billionViewListenView Earnings Details
10/21/2015Q315$1.79$1.80$4.10 billion$4.12 billionViewListenView Earnings Details
7/22/2015Q215$1.78$1.84$4.17 billion$4.27 billionViewListenView Earnings Details
4/22/2015Q115$1.61$1.63$4.01 billion$3.92 billionViewN/AView Earnings Details
1/29/2015Q414$1.94$1.99$4.39 billion$4.49 billionViewN/AView Earnings Details
10/22/2014Q314$1.69$1.71$4.21 billion$4.17 billionViewListenView Earnings Details
7/23/2014Q214$1.62$1.72$4.25 billion$4.32 billionViewN/AView Earnings Details
4/23/2014Q114$1.40$1.53$3.74 billion$3.90 billionViewN/AView Earnings Details
1/31/2014Q413$1.38$1.43$3.31 billion$3.47 billionViewN/AView Earnings Details
10/23/2013Q313$1.28$1.30$3.18 billion$3.19 billionViewListenView Earnings Details
7/24/2013Q2 2013$1.30$1.32$3.22 billion$3.24 billionViewListenView Earnings Details
4/24/2013Q1 2013$1.29$1.37$3.17 billion$3.19 billionViewListenView Earnings Details
1/31/2013Q4 2012$1.28$1.36$3.13 billion$3.26 billionViewListenView Earnings Details
10/24/2012$1.16$1.19ViewN/AView Earnings Details
7/25/2012$1.16$1.22ViewN/AView Earnings Details
4/25/2012$1.11$1.17ViewN/AView Earnings Details
2/1/2012$1.16$1.18ViewN/AView Earnings Details
10/26/2011$1.07$1.07ViewN/AView Earnings Details
7/27/2011$0.98$0.99ViewN/AView Earnings Details
4/27/2011$0.88$0.92ViewN/AView Earnings Details
2/2/2011$0.95$1.00ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Thermo Fisher Scientific (NYSE:TMO)
2017 EPS Consensus Estimate: $9.24
2018 EPS Consensus Estimate: $10.45
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$2.02$2.16$2.07
Q2 20173$2.22$2.27$2.25
Q3 20173$2.25$2.27$2.26
Q4 20173$2.61$2.69$2.66
Q1 20182$2.30$2.31$2.31
Q2 20182$2.55$2.58$2.57
Q3 20182$2.55$2.62$2.59
Q4 20182$2.97$3.02$3.00
(Data provided by Zacks Investment Research)


Current Dividend Information for Thermo Fisher Scientific (NYSE:TMO)
Next Dividend:10/16/2017
Annual Dividend:$0.60
Dividend Yield:0.32%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:10.45% (Trailing 12 Months of Earnings)
6.43% (Based on This Year's Estimates)
5.66% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Dividend History by Quarter for Thermo Fisher Scientific (NYSE TMO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Thermo Fisher Scientific (NYSE:TMO)
Insider Ownership Percentage: 0.49%
Institutional Ownership Percentage: 83.36%
Insider Trades by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Insider Trades by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/5/2017Peter E HornstraVPSell3,894$185.18$721,090.92View SEC Filing  
8/30/2017C Martin HarrisDirectorSell360$180.97$65,149.20View SEC Filing  
8/30/2017Daniel P ShineInsiderSell2,026$180.97$366,645.22View SEC Filing  
8/28/2017Seth H HoogasianVPSell4,140$177.80$736,092.00View SEC Filing  
8/18/2017Jim P ManziDirectorSell11,318$172.94$1,957,334.92View SEC Filing  
8/17/2017Jim P ManziDirectorSell1,000$175.20$175,200.00View SEC Filing  
8/2/2017Gregory J HerremaSVPSell30,000$176.02$5,280,600.00View SEC Filing  
6/5/2017Stephen WilliamsonCFOSell2,500$176.26$440,650.00View SEC Filing  
6/1/2017Marc N CasperCEOSell20,000$172.79$3,455,800.00View SEC Filing  
5/24/2017Daniel P ShineInsiderSell4,688$171.88$805,773.44View SEC Filing  
4/27/2017Thomas W LoewaldInsiderSell1,532$168.76$258,540.32View SEC Filing  
3/15/2017Marc N CasperCEOSell20,000$158.60$3,172,000.00View SEC Filing  
3/15/2017Peter M WilverVPSell9,079$160.73$1,459,267.67View SEC Filing  
3/10/2017Peter M WilverVPSell9,987$158.18$1,579,743.66View SEC Filing  
3/8/2017Thomas W LoewaldInsiderSell7,675$157.39$1,207,968.25View SEC Filing  
3/6/2017Seth H HoogasianVPSell3,142$158.71$498,666.82View SEC Filing  
3/6/2017Stephen WilliamsonCFOSell2,500$158.71$396,775.00View SEC Filing  
3/6/2017Thomas W LoewaldSVPSell4,049$158.71$642,616.79View SEC Filing  
9/2/2016Marc N CasperCEOSell28,797$151.01$4,348,634.97View SEC Filing  
9/1/2016Marc N CasperCEOSell30,000$151.17$4,535,100.00View SEC Filing  
8/29/2016Daniel P ShineSVPSell1,699$152.28$258,723.72View SEC Filing  
8/29/2016Seth H HoogasianVPSell2,270$152.28$345,675.60View SEC Filing  
8/29/2016Thomas W LoewaldInsiderSell3,256$152.28$495,823.68View SEC Filing  
8/26/2016Thomas W LoewaldInsiderSell913$151.92$138,702.96View SEC Filing  
8/10/2016Seth H HoogasianVPSell5,023$156.00$783,588.00View SEC Filing  
8/5/2016C Martin HarrisDirectorSell390$157.33$61,358.70View SEC Filing  
7/13/2016Thomas W LoewaldSVPSell8,025$155.00$1,243,875.00View SEC Filing  
7/5/2016Marc N CasperCEOSell20,000$147.69$2,953,800.00View SEC Filing  
7/1/2016Marc N CasperCEOSell30,000$148.85$4,465,500.00View SEC Filing  
6/15/2016Daniel P ShineSVPSell6,900$148.31$1,023,339.00View SEC Filing  
6/10/2016Peter M WilverVPSell68,200$152.38$10,392,316.00View SEC Filing  
6/3/2016Jim P ManziDirectorSell1,137$153.00$173,961.00View SEC Filing  
6/2/2016Thomas W LoewaldSVPSell15,000$152.84$2,292,600.00View SEC Filing  
5/16/2016Peter E HornstraCAOSell7,811$150.00$1,171,650.00View SEC Filing  
4/26/2016Daniel P ShineSVPSell6,013$146.00$877,898.00View SEC Filing  
4/5/2016Seth H HoogasianVPSell10,000$141.86$1,418,600.00View SEC Filing  
4/4/2016Patrick M DurbinSVPSell16,250$142.18$2,310,425.00View SEC Filing  
3/21/2016Stephen WilliamsonCFOSell10,708$139.50$1,493,766.00View SEC Filing  
3/14/2016Marc N CasperCEOSell30,000$139.28$4,178,400.00View SEC Filing  
3/10/2016Alan J MalusEVPSell25,925$139.05$3,604,871.25View SEC Filing  
3/9/2016Alan J MalusEVPSell15,446$138.50$2,139,271.00View SEC Filing  
3/3/2016Scott M SperlingDirectorSell5,350$137.90$737,765.00View SEC Filing  
3/3/2016Thomas W LoewaldSVPSell3,625$137.28$497,640.00View SEC Filing  
3/1/2016Seth H HoogasianVPSell2,951$135.00$398,385.00View SEC Filing  
2/1/2016Alan J. MalusEVPSell103,400$130.24$13,466,816.00View SEC Filing  
1/15/2016Daniel P. ShineSVPSell6,000$131.77$790,620.00View SEC Filing  
12/14/2015Thomas W. LoewaldSVPSell13,013$134.18$1,746,084.34View SEC Filing  
12/11/2015William G ParrettDirectorBuy1,000$134.16$134,160.00View SEC Filing  
12/7/2015Alan J. MalusEVPSell82,300$135.49$11,150,827.00View SEC Filing  
11/4/2015Seth H HoogasianVPSell1,692$135.00$228,420.00View SEC Filing  
11/3/2015C Martin HarrisDirectorSell531$134.35$71,339.85View SEC Filing  
11/2/2015Jim P. ManziDirectorSell3,050$133.49$407,144.50View SEC Filing  
9/17/2015Marc N CasperCEOSell25,000$130.00$3,250,000.00View SEC Filing  
8/28/2015Alan J MalusEVPSell4,557$127.55$581,245.35View SEC Filing  
7/14/2015Andrew J ThomsonSVPSell5,000$135.23$676,150.00View SEC Filing  
7/14/2015Peter E HornstraCAOSell7,381$136.02$1,003,963.62View SEC Filing  
6/3/2015Tyler JacksDirectorSell15,000$129.95$1,949,250.00View SEC Filing  
6/1/2015Alan J MalusEVPSell40,350$129.54$5,226,939.00View SEC Filing  
5/26/2015Thomas J LynchDirectorSell5,000$131.09$655,450.00View SEC Filing  
5/21/2015Peter M WilverCFOSell28,100$133.00$3,737,300.00View SEC Filing  
4/23/2015Thomas J LynchDirectorSell5,000$130.15$650,750.00View SEC Filing  
4/21/2015Seth H HoogasianVPSell13,256$135.00$1,789,560.00View SEC Filing  
4/13/2015Alan J MalusEVPSell11,032$133.67$1,474,647.44View SEC Filing  
4/13/2015Andrew J ThomsonSVPSell12,425$133.50$1,658,737.50View SEC Filing  
4/1/2015Marc N CasperCEOSell20,000$131.89$2,637,800.00View SEC Filing  
3/30/2015Thomas J LynchDirectorSell5,000$134.40$672,000.00View SEC Filing  
3/30/2015Thomas W LoewaldSVPSell5,307$134.40$713,260.80View SEC Filing  
3/9/2015Alan J MalusEVPSell14,479$128.11$1,854,904.69View SEC Filing  
2/23/2015Edward A PesickaSVPSell28,713$130.93$3,759,393.09View SEC Filing  
2/20/2015Peter M WilverCFOSell50,700$130.12$6,597,084.00View SEC Filing  
2/20/2015Thomas W LoewaldSVPSell15,037$127.94$1,923,833.78View SEC Filing  
2/5/2015Alan J MalusEVPSell50,000$126.83$6,341,500.00View SEC Filing  
12/18/2014Alan J MalusEVPSell11,618$125.20$1,454,573.60View SEC Filing  
11/19/2014Peter E HornstraCAOSell8,363$125.00$1,045,375.00View SEC Filing  
8/27/2014Alan J MalusEVPSell13,115$120.61$1,581,800.15View SEC Filing  
8/27/2014Seth H HoogasianVPSell10,577$120.77$1,277,384.29View SEC Filing  
8/27/2014Thomas W LoewaldSVPSell2,349$120.90$283,994.10View SEC Filing  
7/30/2014Seth H HoogasianVPSell5,103$123.82$631,853.46View SEC Filing  
7/25/2014Thomas W LoewaldSVPSell6,000$125.23$751,380.00View SEC Filing  
4/29/2014Jim ManziDirectorSell3,000$114.85$344,550.00View SEC Filing  
4/28/2014Thomas LoewaldSVPSell8,688$114.49$994,689.12View SEC Filing  
3/24/2014Edward PesickaSVPSell80,044$120.75$9,665,313.00View SEC Filing  
2/26/2014Alan MalusEVPSell7,640$124.11$948,200.40View SEC Filing  
2/14/2014Andrew ThomsonSVPSell16,725$123.14$2,059,516.50View SEC Filing  
2/10/2014Peter HornstraCAOSell9,234$117.72$1,087,026.48View SEC Filing  
2/7/2014Marc CasperCEOSell208,765$115.70$24,154,110.50View SEC Filing  
2/7/2014Peter WilverCFOSell91,897$115.21$10,587,453.37View SEC Filing  
2/6/2014Thomas LoewaldSVPSell22,437$114.24$2,563,202.88View SEC Filing  
2/6/2014William ParrettDirectorSell18,000$114.33$2,057,940.00View SEC Filing  
9/16/2013Alan MalusEVPSell4,000$91.87$367,480.00View SEC Filing  
8/15/2013Alan MalusEVPSell4,000$91.11$364,440.00View SEC Filing  
7/24/2013Edward A PesickaSVPSell80,700$91.00$7,343,700.00View SEC Filing  
6/17/2013Marc N CasperCEOSell43,396$85.58$3,713,829.68View SEC Filing  
6/17/2013Seth H HoogasianVPSell35,431$85.59$3,032,539.29View SEC Filing  
6/10/2013Judy C LewentDirectorSell15,000$85.19$1,277,850.00View SEC Filing  
6/7/2013Edward A PesickaSVPSell167,980$85.28$14,325,334.40View SEC Filing  
5/24/2013C Martin HarrisDirectorSell1,260$87.21$109,884.60View SEC Filing  
5/15/2013Alan J MalusEVPSell4,000$84.43$337,720.00View SEC Filing  
5/14/2013Scott M SperlingDirectorSell8,000$84.65$677,200.00View SEC Filing  
5/7/2013Andrew J ThomsonSVPSell12,700$83.65$1,062,355.00View SEC Filing  
5/7/2013Jim P ManziDirectorSell7,500$82.78$620,850.00View SEC Filing  
11/1/2012Marc N CasperCEOSell125,000$62.49$7,811,250.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Thermo Fisher Scientific (NYSE:TMO)
Latest Headlines for Thermo Fisher Scientific (NYSE:TMO)
DateHeadline logoThermo Fisher, Dominant And Growing - September 23 at 10:09 AM logoThermo Fisher, Dominant And Growing - September 23 at 10:09 AM logoETFs with exposure to Thermo Fisher Scientific, Inc. : September 22, 2017 - September 23 at 10:09 AM logoETFs with exposure to Thermo Fisher Scientific, Inc. : September 22, 2017 - September 23 at 10:09 AM logoValens Groworks Announces Strategic Collaboration - September 23 at 10:08 AM logoValens Groworks Announces Strategic Collaboration - September 23 at 10:08 AM logoThermo Fisher Scientific Inc (TMO) SVP Gregory J. Herrema Sells 30,000 Shares - September 22 at 7:30 PM logoThermo Fisher Scientific Inc (TMO) Raised to Buy at Zacks Investment Research - September 21 at 8:20 PM logoThermo Fisher Scientific Inc (TMO) Downgraded by Zacks Investment Research - September 18 at 12:04 PM logoJefferies Group Research Analysts Raise Earnings Estimates for Thermo Fisher Scientific Inc (TMO) - September 18 at 3:58 AM logoThermo Fisher Fundamentals Impressive Amid Tough Competition - September 15 at 10:00 AM logoThermo Fisher Scientific Inc (TMO) Lifted to "Buy" at Zacks Investment Research - September 14 at 1:04 PM logoS&P 500 Nears 2,500: 5 Stock Picks for Big Profits - September 14 at 11:29 AM logoThermo Fisher Scientific Inc (TMO) Ex-Dividend Date Scheduled for September 14 ... - September 13 at 10:15 AM logoThermo Fisher Scientific Completes Subsequent Offering Period of Tender Offer Following Acquisition of Patheon N.V. - September 13 at 10:15 AM logoThermo Fisher Scientific Inc (TMO) Downgraded to Hold at Zacks Investment Research - September 12 at 1:16 PM logoGarmin Ltd. (GRMN) Ex-Dividend Date Scheduled for September 13, 2017 - Nasdaq - September 12 at 11:03 AM logoEx-Dividend Reminder: Thermo Fisher Scientific, Conmed and Merck - Nasdaq - September 12 at 11:03 AM logoFive Healthcare Stocks To Buy Before The End Of The Year - September 12 at 11:02 AM logoThermo Fisher Scientific Inc (TMO) Expected to Post Quarterly Sales of $5.05 Billion - September 12 at 9:44 AM logoThermo Fisher Scientific's (TMO) Buy Rating Reaffirmed at Cowen and Company - September 10 at 8:24 AM logo8 Factors That Make Thermo Fisher a Valuable Pick Right Now - Nasdaq - September 8 at 9:21 AM logoMicron, Square, Thermo Fisher: Fast Money Picks For September 8 - Benzinga - September 8 at 9:21 AM logoZacks Investment Research Upgrades Thermo Fisher Scientific Inc (TMO) to Buy - September 7 at 12:00 PM logo8 Factors That Make Thermo Fisher a Valuable Pick Right Now - September 7 at 9:59 AM logoHead to Head Analysis: Thermo Fisher Scientific (TMO) & PerkinElmer (PKI) - September 7 at 6:16 AM logoBiocartis Group NV: Biocartis announces H1 2017 results - September 7 at 2:40 AM logoThermo Fisher Scientific Inc (TMO) VP Sells $721,090.92 in Stock - September 6 at 7:58 PM logoThermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare ... - September 6 at 9:14 AM logoThermo Fisher Scientific Inc (TMO) Coverage Initiated by Analysts at Morgan Stanley - September 6 at 8:38 AM logoThermo Fisher Scientific Inc (TMO) Given Average Rating of "Buy" by Brokerages - September 6 at 12:36 AM logoThermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 11, 2017 - September 5 at 9:20 AM logoThermo Fisher Scientific Inc (TMO) Receives Buy Rating from Cowen and Company - September 4 at 9:26 PM logoThermo Fisher Scientific Inc to Post Q3 2017 Earnings of $2.27 Per Share, Jefferies Group Forecasts (TMO) - September 4 at 1:12 AM logoC Martin Harris Sells 360 Shares of Thermo Fisher Scientific Inc (TMO) Stock - August 31 at 7:58 PM logoInsider Selling: Thermo Fisher Scientific Inc (TMO) Insider Sells 2,026 Shares of Stock - August 31 at 7:22 PM logoThermo Fisher Completes Patheon Acquisition - Quick Facts - August 31 at 11:04 AM logoThermo Fisher Scientific (TMO) Closes Acquisition of Patheon - August 31 at 11:04 AM logoThermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research ... - August 31 at 11:04 AM logoFirst FDA-Approved Cell Therapy for Leukemia Utilizes Thermo Fisher Scientific's CTS Dynabeads Technology - August 31 at 11:03 AM logoThermo Fisher Scientific (TMO) Closes Acquisition of Patheon - - August 30 at 10:18 AM logoThermo Fisher Scientific Inc (TMO) VP Seth H. Hoogasian Sells 4,140 Shares - August 29 at 7:18 PM logoThermo Fisher (TMO) Up 1.9% Since Earnings Report: Can It Continue? - August 29 at 8:47 AM logoNoteworthy ETF Outflows: IHI, TMO, DHR, BDX - Nasdaq - August 26 at 9:28 AM logoThermo Fisher Scientific (TMO) Receives ll Required Regulatory Approvals for Proposed Acquisition of Patheon (PTHN) - - August 25 at 1:04 AM logoBRIEF-Thermo Fisher Scientific announces receipt of all required regulatory approvals for proposed acquisition of Patheon - August 24 at 2:56 PM logoThermo Fisher on go with Patheon buy - August 24 at 2:56 PM logoThermo Fisher Scientific (TMO) Receives ll Required Regulatory Approvals for Proposed Acquisition of Patheon (PTHN) - August 24 at 2:56 PM logoThermo Fisher Scientific Inc. Expected to Earn Q3 2017 Earnings of $2.25 Per Share (TMO) - August 24 at 6:26 AM logoMKS Instruments, Inc. (MKSI) Ex-Dividend Date Scheduled for August 24, 2017 - Nasdaq - August 23 at 12:41 PM



Thermo Fisher Scientific (TMO) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by Staff